doi: 10.1007/BF02798479.
Monoclonal antibodies and immobilized antibodies. Patents and literature
- PMID: 3901916
- DOI: 10.1007/BF02798479
Item in Clipboard
Monoclonal antibodies and immobilized antibodies. Patents and literature
Appl Biochem Biotechnol.
1985 Jun.
No abstract available
Similar articles
-
Monoclonal antibodies for clinical applications. Patents and literature.Appl Biochem Biotechnol. 1988 Dec;19(3):271-96. doi: 10.1007/BF02921499. Appl Biochem Biotechnol. 1988. PMID: 3072927
-
Monoclonal antibodies and immobilized antibodies. Patents and literature.Appl Biochem Biotechnol. 1987 Jun;15(1):53-80. doi: 10.1007/BF02798506. Appl Biochem Biotechnol. 1987. PMID: 3662496
-
Immobilized biocatalysts. Patents and literature.Appl Biochem Biotechnol. 1985 Apr;11(2):153-67. doi: 10.1007/BF02798547. Appl Biochem Biotechnol. 1985. PMID: 3916466 No abstract available.
-
[Inventions in neurosurgery in the last 10 years].Zh Vopr Neirokhir Im N N Burdenko. 1987 Nov-Dec;(6):41-54. Zh Vopr Neirokhir Im N N Burdenko. 1987. PMID: 3327329 Review. Russian. No abstract available.
-
The Ecstacy of Gold: Patent Expirations for Trastuzumab, Bevacizumab, Rituximab, and Cetuximab.Recent Pat Biotechnol. 2018;12(2):101-112. doi: 10.2174/1872208311666171122152131. Recent Pat Biotechnol. 2018. PMID: 29173192 Review.